XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Accrued Expenses and Other Current Liabilities (Tables)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Accrued Expenses and Other Current Liabilities [Abstract]    
Schedule of Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following as of the periods indicated:
   March 31,   December 31, 
   2024   2023 
Accrued research and development expense  $1,799,583   $1,799,583 
Accrued compensation and employee benefits   1,061,083    1,184,505 
Accrued royalties   262,296    274,028 
Others   927,883    438,264 
Total  $4,050,845   $3,696,380 
 Accrued expenses and other current liabilities consisted of the following as of the periods indicated:
   December 31,   December 31, 
   2023   2022 
Accrued research and development expense  $1,799,583   $1,600,221 
Accrued compensation and employee benefits   1,184,505    568,865 
Accrued royalties   274,028    272,352 
Others   438,264    468,150 
Total  $3,696,380   $2,909,587